10 Jul Emerging Threat: Detection of High-Risk Substances in the Absence of Fentanyl
While designer opioids and illicit adulterants (e.g., xylazine, medetomidine) are most frequently found in specimens containing fentanyl, designer...
Archive
15 Jun Emerging Threat: Kratom Alkaloids
Kratom is a psychoactive botanical derived from the leaves of the mitragyna speciosa tree, which is indigenous to Southeast Asia....
18 Mar Emerging Threat: N-Propionitrile Chlorphine (Cychlorphine)
Cyclorphine, also known as N‑propionitrile chlorphine, is a novel synthetic opioid belonging to the “orphine” subclass of benzimidazolone‑derived...
16 Mar Emerging Threat: New Fentanyl Analogs Highlight the Need for Definitive Testing
ortho-Methylfentanyl is an Illicitly-manufactured fentanyl analog that is currently considered a Schedule I drug in the US. It is a...
15 Mar Emerging Threat: Xylazine and Medetomidine
Xylazine is a tranquilizer frequently found as an adulterant in the illicit drug supply and medetomidine is an alpha-2 adrenergic...
15 Nov Emerging Threat: Phenazolam
Phenazolam, also known as clobromazolam, was first reported as detected in the United States in 2022. Though bromazolam has been...
